Corcept Therapeutics Inc SEC filings CORT
Corcept Therapeutics Inc has 1,001 filings in SEC EDGAR's recent list, going back to Mar 10, 2016. Its latest annual report, Form 10-K, was filed on Feb 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| UPLOAD | Letter from the SEC | Dec 11, 2025 | — |
| CORRESP | Letter to the SEC | Oct 1, 2025 | — |
| UPLOAD | Letter from the SEC | Sep 18, 2025 | — |
| UPLOAD | Letter from the SEC | Aug 24, 2023 | — |
| CORRESP | Letter to the SEC | Aug 15, 2023 | — |
| UPLOAD | Letter from the SEC | Aug 7, 2023 | — |
| SC TO-I/A | Filing | Apr 5, 2023 | — |
| SC TO-I/A | Filing | Apr 3, 2023 | — |
| SC TO-I/A | Filing | Mar 7, 2023 | — |
| SC TO-I | Filing | Mar 6, 2023 | — |
| SC TO-I/A | Filing | Dec 20, 2021 | — |
| SC TO-I/A | Filing | Dec 16, 2021 | — |
| SC TO-I/A | Filing | Dec 15, 2021 | — |
| SC TO-I/A | Filing | Dec 8, 2021 | — |
| UPLOAD | Letter from the SEC | Nov 16, 2021 | — |
| CORRESP | Letter to the SEC | Nov 15, 2021 | — |
| UPLOAD | Letter from the SEC | Nov 10, 2021 | — |
| SC TO-I | Filing | Nov 8, 2021 | — |
| UPLOAD | Letter from the SEC | Dec 23, 2020 | — |
| CORRESP | Letter to the SEC | Dec 14, 2020 | — |
| UPLOAD | Letter from the SEC | Nov 10, 2020 | — |
| CT ORDER | Filing | Mar 18, 2019 | — |
| CT ORDER | Filing | Jan 18, 2018 | — |
| UPLOAD | Letter from the SEC | Sep 25, 2017 | — |
| CORRESP | Letter to the SEC | Sep 22, 2017 | — |
| UPLOAD | Letter from the SEC | Sep 12, 2017 | — |
| EFFECT | Filing | May 10, 2017 | — |
| CORRESP | Letter to the SEC | May 8, 2017 | — |
| CORRESP | Letter to the SEC | Apr 25, 2017 | — |
Showing 29 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CORT (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Redwood City, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1088856
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.